You have no items in your shopping cart.
Description
GSK 126 is a very high affinity and selective EZH2 inhibitor (Ki = 0.5 - 3 nM). Exhibits >150-fold selectivity for EZH2 over EZH1 and >1000-fold selectivity over 20 other human methyltransferases. Inhibits proliferation of B-cell lymphoma cell lines in vitro. Also inhibits H3K27Me3 and tumor growth in mice bearing BCL xenografts. Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection. Promotes the transition of ESCs to feeder-free extended pluripotent stem (EPS) cells in combination with LCDM cocktail.
For research use only. We do not sell to patients.
Specification
Chemical Name | N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide |
M. Wt | 526.67 |
Formula | 3.47594%;">C31H38N6O2 |
Storage | Store at -20°C |
Purity | ≥98% |
CAS No. | 1346574-57-9 |
PubChem ID | 68210102 |
InChI Key |
FKSFKBQGSFSOSM-QF IPXVFZSA-N |
SMILES | CC1=CN([C@@H](C)CC)C2=CC(C(C=C3)=CN=C3N4CCNCC4)=CC(C(NCC5=C(C)C=C(C)NC5=O)=O)=C21 |
Disclaimer: For laboratory research use only.
When can I expect my order to ship?
Most orders are filled and shipped within 2-3 business days from the time they are received.
Our standard shipping usually take 2-5 days.
We also provide express shippping for time-sensitive deliveries.
Email contact@biofargo.com if you have any requirements.